The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACRIVON THERAPEUTICS INC | COMMON STOCK | 004890109 | 3,273,995 | 284,201 | SH | SOLE | 284,201 | 0 | 0 | |||
| ALKERMES PLC | SHS | G01767105 | 2,874,300 | 110,000 | SH | SOLE | 110,000 | 0 | 0 | |||
| BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 38,059,999 | 367,765 | SH | SOLE | 367,765 | 0 | 0 | |||
| BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 1,314,300 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | |||
| CHINOOK THERAPEUTICS INC | COM | 16961L106 | 1,572,000 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | |||
| CONMED CORP | COM | 207410101 | 2,437,600 | 27,500 | SH | SOLE | 27,500 | 0 | 0 | |||
| CYTOKINETICS INC | COM NEW | 23282W605 | 7,534,640 | 164,440 | SH | SOLE | 164,440 | 0 | 0 | |||
| DEXCOM INC | COM | 252131107 | 36,393,071 | 321,380 | SH | SOLE | 321,380 | 0 | 0 | |||
| EQRX INC | *W EXP 12/17/202 | 26886C115 | 9,451 | 35,239 | SH | SOLE | 35,239 | 0 | 0 | |||
| EUCRATES BIOMEDICAL ACQU COR | *W EXP 10/23/202 | G3141W122 | 4,340 | 78,059 | SH | SOLE | 78,059 | 0 | 0 | |||
| GERON CORP | COM | 374163103 | 1,210,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | |||
| HYPERFINE INC | COM CL A | 44916K106 | 3,259,956 | 3,880,900 | SH | SOLE | 3,880,900 | 0 | 0 | |||
| IMMUNOGEN INC | COM | 45253H101 | 744,000 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | |||
| INSPIRE MED SYS INC | COM | 457730109 | 881,580 | 3,500 | SH | SOLE | 3,500 | 0 | 0 | |||
| INTUITIVE SURGICAL INC | COM NEW | 46120E602 | 1,525,762 | 5,750 | SH | SOLE | 5,750 | 0 | 0 | |||
| MEDICUS SCIENCES ACQUISITION | *W EXP 02/12/202 | G5960S124 | 2,679 | 29,776 | SH | SOLE | 29,776 | 0 | 0 | |||
| NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 2,388,800 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | |||
| PENUMBRA INC | COM | 70975L107 | 1,112,300 | 5,000 | SH | SOLE | 5,000 | 0 | 0 | |||
| RAIN ONCOLOGY INC | COM | 75082Q105 | 960,000 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | |||
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 978,500 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | |||
| SILK RD MED INC | COM | 82710M100 | 792,750 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | |||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 1,781,500 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | |||